Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05945576

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

National Cohort on Imprinting Disorders and Their Metabolic Consequences

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center. The main questions it aims to answer are: * Can we identify common metabolic profiles for all imprinted diseases? * Which imprinting disorders have an impact on the metabolic profiles of IDs? * Which are the metabolic risks associated to IDs? * Can we use the metabolic profiles for the clinical classification and prognosis of IDs? * Are there common therapeutic approaches for all IDs?

Conditions

Timeline

Start date
2017-03-10
Primary completion
2028-03-01
Completion
2028-03-01
First posted
2023-07-14
Last updated
2026-02-12

Locations

20 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05945576. Inclusion in this directory is not an endorsement.

IDMet (RaDiCo Cohort) (RaDiCo-IDMet) (NCT05945576) · Clinical Trials Directory